InvestorsHub Logo
Followers 30
Posts 2195
Boards Moderated 0
Alias Born 12/13/2016

Re: jtsmgoblue post# 160194

Saturday, 07/28/2018 2:25:41 AM

Saturday, July 28, 2018 2:25:41 AM

Post# of 462186
JTSG......there has been much conjecture on the board about the lash-up between Anavex and Biogen because the their mutual focus on neurodegenerative diseases and the now long running MTA of 2-73.

I have previously commented that the discussions between the two have more than likely been on a business level as well as scientific. That these talks have not previously been acknowledged, points to monetary differences between between the two for a proposed partnership/licensing deal.

IMHO Biogen's BOD is asking Micheal Vounatosis about what went wrong at the AAIC and how 2-73 has apparently (despite being in Biogen's lab for a very extended time) upstaged BAN2401.. I believe that the level of conversation/negotiation has ratcheted up since Wednesday.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News